Search Results - "WARD, T. H"

Refine Results
  1. 1

    Biomarker method validation in anticancer drug development by Cummings, J, Ward, T H, Greystoke, A, Ranson, M, Dive, C

    Published in British journal of pharmacology (01-02-2008)
    “…Over recent years the role of biomarkers in anticancer drug development has expanded across a spectrum of applications ranging from research tool during early…”
    Get full text
    Journal Article
  2. 2

    Biomarkers of apoptosis by Ward, T H, Cummings, J, Dean, E, Greystoke, A, Hou, J M, Backen, A, Ranson, M, Dive, C

    Published in British journal of cancer (16-09-2008)
    “…Within the era of molecularly targeted anticancer agents, it has become increasingly important to provide proof of mechanism as early on as possible in the…”
    Get full text
    Journal Article
  3. 3

    Noninvasive fluorescence imaging of small animals by ZELMER, A., WARD, T.H.

    Published in Journal of microscopy (Oxford) (01-10-2013)
    “…Summary Noninvasive in vivo fluorescence imaging of small animals as a method in preclinical research has developed considerably in recent years, and is used…”
    Get full text
    Journal Article
  4. 4

    Oxaliplatin responses in colorectal cancer cells are modulated by CHK2 kinase inhibitors by Pires, IM, Ward, TH, Dive, C

    Published in British journal of pharmacology (01-03-2010)
    “…Background and purpose:  Checkpoint kinase 2 (CHK2) is activated by DNA damage and can contribute to p53 stabilization, modulating growth arrest and/or…”
    Get full text
    Journal Article
  5. 5

    Validation of pharmacodynamic assays to evaluate the clinical efficacy of an antisense compound (AEG 35156) targeted to the X-linked inhibitor of apoptosis protein XIAP by CUMMINGS, J, WARD, T. H, LACASSE, E, LEFEBVRE, C, ST-JEAN, M, DURKIN, J, RANSON, M, DIVE, C

    Published in British journal of cancer (14-02-2005)
    “…The inhibitor of apoptosis protein, XIAP, is frequently overexpressed in chemoresistant human tumours. An antisense oligonucleotide (AEG 35156/GEM 640) that…”
    Get full text
    Journal Article
  6. 6

    Phase I pharmacokinetic and pharmacodynamic study of the bioreductive drug RH1 by Danson, S.J., Johnson, P., Ward, T.H., Dawson, M., Denneny, O., Dickinson, G., Aarons, L., Watson, A., Jowle, D., Cummings, J., Robson, L., Halbert, G., Dive, C., Ranson, M.

    Published in Annals of oncology (01-07-2011)
    “…This trial describes a first-in-man evaluation of RH1, a novel bioreductive drug activated by DT-diaphorase (DTD), an enzyme overexpressed in many tumours. A…”
    Get full text
    Journal Article
  7. 7

    DT-diaphorase: a target for new anticancer drugs by Danson, S, Ward, T.H, Butler, J, Ranson, M

    Published in Cancer treatment reviews (01-08-2004)
    “…DT-diaphorase (DTD) is an obligate two-electron reductase which bioactivates chemotherapeutic quinones. DTD levels are elevated in a number of tumour types,…”
    Get full text
    Journal Article
  8. 8

    ‘Fit-for-purpose’ validation of SearchLight multiplex ELISAs of angiogenesis for clinical trial use by Backen, A.C., Cummings, J., Mitchell, C., Jayson, G., Ward, T.H., Dive, C.

    Published in Journal of immunological methods (15-03-2009)
    “…Validated assays of circulating biomarkers of angiogenesis to predict and determine the efficacy of vascular-targeted anticancer drugs would facilitate…”
    Get full text
    Journal Article
  9. 9

    Validation of an ELISA for the determination of rituximab pharmacokinetics in clinical trials subjects by Hampson, G., Ward, T.H., Cummings, J., Bayne, M., Tutt, A.L., Cragg, M.S., Dive, C., Illidge, T.M.

    Published in Journal of immunological methods (31-08-2010)
    “…Rituximab is a chimeric anti-CD20 monoclonal antibody that has revolutionised the treatment of many B-cell malignancies, and is now increasingly being used in…”
    Get full text
    Journal Article
  10. 10

    Hypoxia in head and neck cancer by ISA, A. Y, WARD, T. H, WEST, C. M. L, SLEVIN, N. J, HOMER, J. J

    Published in British journal of radiology (01-10-2006)
    “…A high level of hypoxia in solid tumours is an adverse prognostic factor for the poor outcome of cancer patients following treatment. This review describes the…”
    Get full text
    Journal Article
  11. 11

    Validation of the comet-X assay as a pharmacodynamic assay for measuring DNA cross-linking produced by the novel anticancer agent RH1 during a phase I clinical trial by DANSON, S, RANSON, M, DENNENY, O, CUMMINGS, J, WARD, T. H

    Published in Cancer chemotherapy and pharmacology (01-11-2007)
    “…RH1 is a novel anticancer agent with potent DNA-cross linking activity. RH1 has the potential to be activated within tumors over expressing NQO1, giving…”
    Get full text
    Journal Article
  12. 12

    Dynamics of proteins in Golgi membranes: comparisons between mammalian and plant cells highlighted by photobleaching techniques by Ward, T H, Brandizzi, F

    “…In less than a decade the green fluorescent protein (GFP) has become one of the most popular tools for cell biologists for the study of dynamic processes in…”
    Get full text
    Journal Article
  13. 13

    Ethanol-induced free radicals and hepatic DNA strand breaks are prevented in vivo by antioxidants: effects of acute and chronic ethanol exposure by Navasumrit, Panidz, Ward, Timothy H., Dodd, Nicholas J.F., O'Connor, Peter J.

    Published in Carcinogenesis (New York) (01-01-2000)
    “…Ethanol was given to male Wistar rats as an acute dose (5 g/kg) or continuously at 5% (w/v) in a liquid diet to provide 36% of the caloric requirement. Free…”
    Get full text
    Journal Article
  14. 14

    Fern spore extracts can damage DNA by SIMAN, S. E, POVEY, A. C, WARD, T. H, MARGISON, G. P, SHEFFIELD, E

    Published in British journal of cancer (01-07-2000)
    “…The carcinogenicity of the vegetative tissues of bracken fern (Pteridium) has long been established. More recently, the carcinogenic effects of the spores of…”
    Get full text
    Journal Article
  15. 15

    DNA Damage and Repair in Gorlin Syndrome and Normal Fibroblasts After Aminolevulinic Acid Photodynamic Therapy: A Comet Assay Study by Haylett, A. K., Ward, T. H., Moore, J. V.

    Published in Photochemistry and photobiology (01-10-2003)
    “…Using normal, untransformed, human fibroblasts, the effectiveness of aminolevulinic (ALA)-mediated photodynamic therapy (PDT) was investigated in terms of both…”
    Get full text
    Journal Article
  16. 16

    Influence of extracellular pH on the cytotoxicity and DNA damage of a series of indolequinone compounds by Phillips, R M, Ward, T H

    Published in Anticancer research (01-05-2001)
    “…The existence of an acidic extracellular pH (pHe) within solid tumours is regarded as a potential target for drug development. The indolequinone EO9 has a…”
    Get more information
    Journal Article
  17. 17

    Quantitative multiplexed quantum dot immunohistochemistry by Sweeney, E., Ward, T.H., Gray, N., Womack, C., Jayson, G., Hughes, A., Dive, C., Byers, R.

    “…Quantum dots are photostable fluorescent semiconductor nanocrystals possessing wide excitation and bright narrow, symmetrical, emission spectra. These…”
    Get full text
    Journal Article
  18. 18

    A retrospective case note review of deceased recipients of vCJD-implicated blood transfusions by Gillies, M., Chohan, G., Llewelyn, C. A., MacKenzie, J., Ward, H. J. T., Hewitt, P. E., Will, R. G.

    Published in Vox sanguinis (01-10-2009)
    “…Background  To date, four instances of probable transfusion–transmission of variant Creutzfeldt–Jakob disease (vCJD) infection have been described, and…”
    Get full text
    Journal Article
  19. 19

    Electrochemical Monitoring of Anticancer Compounds on the Human Ovarian Carcinoma Cell Line A2780 and Its Adriamycin- and Cisplatin-Resistant Variants by Woolley, D.E., Tetlow, L.C., Adlam, D.J., Gearey, D., Eden, R.D., Ward, T.H., Allen, T.D.

    Published in Experimental cell research (01-02-2002)
    “…A novel electrochemical technique which detects and monitors real-time changes in cell behavior in vitro has been used to examine the effects of recognized…”
    Get full text
    Journal Article
  20. 20

    Maintenance of Golgi Structure and Function Depends on the Integrity of ER Export by Ward, Theresa H., Polishchuk, Roman S., Caplan, Steve, Hirschberg, Koret, Lippincott-Schwartz, Jennifer

    Published in The Journal of cell biology (12-11-2001)
    “…The Golgi apparatus comprises an enormous array of components that generate its unique architecture and function within cells. Here, we use quantitative…”
    Get full text
    Journal Article